ArticleJournal of dental sciences2026
Evaluating thymol vapor for biofilm removal and biocompatibility in curved root canal models
Article in Journal of dental sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- From Plant-Derived Compound to Bioactive Agent in Dentistry: The Expanding Role of Thymol.Dentistry journal · 2026Review
- Thymol as a natural monoterpenoid antibacterial agent: a comprehensive review of applications and current advances.Archives of microbiology · 2026Review
- Modulatory Effects of Bioactive Phytoconstituents on the Amplitude and Gating Properties of Membrane Ion Channels.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose: Conventional irrigants such as chlorhexidine and sodium hypochlorite have strong antimicrobial properties but high cytotoxicity, limiting their use in regenerative endodontics. We hypothesized that thymol vapor could provide effective antibacterial activity with lower cytotoxicity. Materials and methods: The antimicrobial activity of thymol in both liquid and vapor phases was tested against Results: Thymol exhibited minimum inhibition concentration (MIC) and minimum bactericidal concentration (MBC) values of 0.8-1.0 mg/mL in planktonic cultures. In early-stage biofilms models, 10-100 mg/mL liquid thymol and 5.0 mg/mL thymol vapor significantly reduced bacterial viability. Combining 1.0 mg/mL thymol vapor with mechanical instrumentation enhanced early-stage biofilms removal, particularly against Conclusion: This study is the first to propose thymol vapor for biofilm removal in curved root canal models and to demonstrate its antibacterial activity with lower cytotoxicity than conventional irrigants. Its potential as an adjunct in regenerative endodontics merits further investigation, particularly in relation to immunomodulatory effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.